Research Reports
Macleods Pharmaceuticals Ltd Unlisted Shares
Macleods Pharmaceuticals Ltd Share Price
PHYSICAL
PUBLIC LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹505
Low
₹505
Return
-
Macleods Pharmaceuticals Ltd Essentials
As of April 30, 2026, Macleods Pharmaceuticals Ltd, Unlisted Shares are trading at ₹505.00 per share and face value is ₹1.00/share, with a 52-week high of ₹505.00 and 52-week low of ₹505.00. The minimun lot size is None shares, and the shares are traded on .
ISIN
INE05JF01026
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
1
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
59,88,20,400
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
30,240.43 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
1,328.26 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
8,207.09 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
24.62
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
6.85
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Mid Cap
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
1,439.59 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About Macleods Pharmaceuticals Ltd
Company Overview:
- Macleods Pharmaceuticals is engaged in the development, manufacturing, marketing, and distribution of various formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
- Macleods Pharmaceuticals caters to therapies such as antituberculosis, antimalarials, antiretrovirals, antibacterial, antidiabetics, antihypertensives, and antiasthmatics. The company is also known for the number of WHO-pre qualified medicines, used in the treatment of HIV/AIDS, Malaria, Tuberculosis (TB), and opportunistic infections.
- The company has the highest number of WHO pre-qualified products globally with 65 registrations, and the highest number of WHO pre-qualified anti-TB product registrations with 32 registrations.
- Macleods Pharmaceuticals has a strong international presence and exports its products to over 100 countries worldwide. The company has subsidiaries and offices in several countries including the United States, the United Kingdom, Spain, South Africa, Russia, Malaysia, and Ukraine, etc.
- The company had a portfolio of 595 brands in the Indian Pharmaceutical Market in FY21 with 2 brands in the top 100 Indian brands. The company had successfully scaled new brands in short durations, with the brand Panderm++ crossing ₹ 1 bn in domestic sales.
- The company also ranked 1st in the molecular group of Clobetasol, Miconazole, and Neomycin in the Indian Pharmaceutical Market in terms of sales. The company launched new brands Vildamac and Vildamac M in the anti-diabetic market.
- Macleods Pharma has the state of the art manufacturing facilities that comply with international quality standards. The company has manufacturing units spread across India such as Daman, Baddi, Sikkim, Indore, Palghar, Dahej, and Sarigam.
- Macleods Pharmaceuticals adheres to regulatory guidelines and complies with regulations set by regulatory authorities in the countries where it operates. This includes compliance with regulatory bodies such as the U.S. Food and Drug Administration (FDA), the Medicines and Healthcare Products. Regulatory Agency (MHRA) in the UK, and others.
- Macleods Pharmaceuticals was founded in the year 1986 by Dr. R. A. Agarwal along with his two brothers - Girdhari Lal and Banwari Lal. The company got incorporated as a Public Limited company on 5th June in the year 1989 and is the seventh largest pharma company in India with a sales team of more than 4,900 medical representatives.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Macleods Pharmaceuticals Ltd Media
News
Articles
Videos
Macleods Pharma Wins Legal Battle Over Linagliptin Patent
20 Jan 2025
• Medical Dialogues
Macleods Pharma recalls 10,000 bottles of anti-bacterial medication in US over labeling error
25 Jan 2023
• Live Mint
Macleods Pharmaceuticals' purchases Juhu property for Rs 3.32 billion
14 Sep 2022
• Construction World
Macleods Pharmaceuticals Ltd
₹ 505
